Christopher N. Ta MD
Anterior Segment Related, Cornea & External Disease, Refractive Surgery
Professor, Ophthalmology, Stanford University Medical Center
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-725-6619
Dr. Ta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Christopher N. Ta, MD specializes in the diagnosis and treatment of cornea diseases including medical and surgical management. His areas of expertise are in the treatment of ocular infections, inflammation, dry eyes and ocular surface diseases. He has conducted numerous clinical trials toward the prevention and treatment of ocular infections. Dr. Ta’s interests include diagnostic testing and evaluation of novel drugs and devices in the treatment of ocular surface diseases. Dr. Ta has extensive clinical experience in the treatment of ocular graft-versus host disease following hematopoietic stem cell transplantation.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery, 1998 - 1999
Stanford Health Care-Sponsored Stanford UniversityResidency, Ophthalmology, 1995 - 1998
Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1994 - 1995
University of Minnesota Medical SchoolClass of 1994
University of MinnesotaBA, Human Physiology, 1987 - 1990
Certifications & Licensure
CA State Medical License 1995 - 2027
TX State Medical License 1998 - 1999
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- One Hour Preoperative Gatifloxacin Start of enrollment: 2007 Jan 01
- Topical Antibiotics and Intravitreous Injections Start of enrollment: 2008 Jul 01
- Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application Start of enrollment: 2007 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Corneally displaced conjunctival Melanoma: Rare presentations of recurrent melanoma.Eric Boya Lee, Ahmad Al-Moujahed, Michael D Yu, Christopher N Ta, Jonathan H Lin
American Journal of Ophthalmology Case Reports. 2025-09-01 - 3 citationsOverview of Mycotic Keratitis.Alejandro Arboleda, Christopher N Ta
Cornea. 2024-09-01 - 18 citationsTherapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery.Behnam Abdi, Mohammad Mofidfar, Fatemeh Hassanpour, Emel Kirbas Cilingir, Sepideh K Kalajahi
International Journal of Pharmaceutics. 2023-05-10
Grant Support
- Artificial Cornea Based On Photolithographically Patterned, Biomimetic HydrogelsNational Eye Institute2007–2010
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
